Evidence map›Paper›PMID 23475976›Full record

ArticleJournal of bacteriology2013

A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.

Dana E Harmon, Julia L Murphy, Alison J Davis, Joan Mecsas

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. The type III secretion system needle, tip, and translocon.Protein science : a publication of the Protein Society · 2019
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dana E HarmonMolecular Microbiology Graduate Program, Sackler School of Biomedical Sciences School of Medicine, Tufts University, Boston, Massachusetts, USA.
Julia L Murphy
Alison J Davis
Joan Mecsas
Tufts University · US

Funding

MOLECULAR ANALYSIS OF MICROBIAL PATHOGENST32AI007422 · NIAID · TUFTS UNIVERSITY BOSTON · PI Ralph R. Isberg · 1992 to 2026
$5.7M
Inhibitors of Type III Secretion and Translocation in yersiniaR56AI073759 · NIAID · TUFTS UNIVERSITY BOSTON · PI MECSAS, JOAN C · 2008 to 2009
$824k
Role of the Y. pseudotuberculosis YscF protein in toxin delivery into host cellsK01DK075720 · NIDDK · TUFTS UNIVERSITY BOSTON · PI DAVIS, ALISON J · 2007 to 2011
$603k
Inhibitors of Yersinia Yop Type III Secretion(RMI)R21NS053740 · NINDS · TUFTS UNIVERSITY BOSTON · PI MECSAS, JOAN C. · 2005 to 2005
$181k
NIAID NIH HHS AI073759NIAID NIH HHS R56 AI073759NIAID NIH HHS T32 AI007422NIAID NIH HHS T32AI007422NIDDK NIH HHS DK075720NIDDK NIH HHS K01 DK075720NINDS NIH HHS R21 NS053740
6 · The paper itself

Abstract

The plasmid-encoded type three secretion system (TTSS) of Yersinia spp. is responsible for the delivery of effector proteins into cells of the innate immune system, where these effectors disrupt the target cells' activity. Successful translocation of effectors into mammalian cells requires Yersinia to both insert a translocon into the host cell membrane and sense contact with host cells. To probe the events necessary for translocation, we investigated protein-protein interactions among TTSS components of the needle-translocon complex using a chemical cross-linking-based approach. We detected extracellular protein complexes containing YscF, LcrV, and YopD that were dependent upon needle formation. The formation of these complexes was evaluated in a secretion-competent but translocation-defective mutant, the YscFD28AD46A strain (expressing YscF with the mutations D28A and D46A). We found that one of the YscF and most of the LcrV and YopD cross-linked complexes were nearly absent in this mutant. Furthermore, the YscFD28AD46A strain did not support YopB insertion into mammalian membranes, supporting the idea that the LcrV tip complex is required for YopB insertion and translocon formation. However, the YscFD28AD46A strain did secrete Yops in the presence of host cells, indicating that a translocation-competent tip complex is not required to sense contact with host cells to trigger Yop secretion. In conclusion, in the absence of cross-linkable LcrV-YscF interactions, translocon insertion is abolished, but Yersinia still retains the ability to sense cell contact.

Indexed as

Antigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsBiological TransportCell LineHost-Pathogen InteractionsHumansImmunoprecipitationPore Forming Cytotoxic ProteinsProtein BindingYersinia pseudotuberculosisAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsLcrV protein, YersiniaPore Forming Cytotoxic ProteinsYopB protein, YersiniaYopD protein, YersiniaYscF protein, Yersinia pestis

Identifiers

PMID23475976
PMCPMC3650545
OpenAlexW2158657729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.